Search Result "trabedersen (AP 12009)"


The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 2203-2213
Author(s): Frank Jaschinski, Tanja Rothhammer, Piotr Jachimczak, Christian Seitz, Anneliese Schneider, Karl-Hermann Schlingensiepen

Transforming Growth Factor Beta in Pancreatic Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 2158-2164
Author(s): Andreas Hilbig, Helmut Oettle

TGF-β2 Signaling in High-Grade Gliomas

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 2150-2157
Author(s): Peter Hau, Piotr Jachimczak, Jurgen Schlaier, Ulrich Bogdahn

Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases

Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 29-43
Author(s): Ota Fuchs

Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 2121-2137
Author(s): Jeroen T. Buijs, Patricia Juarez, Theresa A. Guise

Nucleic Acid-based Technologies in Therapy of Malignant Gliomas

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 1805-1822
Author(s): Monika Piwecka, Katarzyna Rolle, Eliza Wyszko, Ryszard Zukiel, Stanislaw Nowak, Miroslawa Z. Barciszewska, Jan. Barciszewski

TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 2190-2202
Author(s): Leona E. Ling, Wen-Cherng Lee

Results 1 - 1 of 7

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy